$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
The gastrointestinal (GI) mucosa creates a physical barrier that separates the extracellular environment and the internal host milieu, and is involved in the absorption of nutrients, water and electrolytes. The intestinal barrier encompasses a mucus layer constituted of glycoproteins, a monolayer of epithelial cells, and the underlying lamina propria are immune and stromal cells reside. Intestinal epithelial cells forming the physical barrier are linked together by different protein complexes, which includes the adherens junction (AJ), the tight junction (TJ) and the desmosomes (DMs). Impairment in the epithelial barrier function augments intestinal permeability and allows the translocation of harmful substances and pathogens from the lumen to the interstitium1. There is an increasing number of illnesses where the epithelial barrier is compromised, such as the inflammatory bowel diseases (IBD) like Crohn's disease (CD), ulcerative colitis (UC) and indeterminate colitis (IC). The incidence of IBD is increasing worldwide, with a prevalence approaching 0.5% in the West. Although the causes of IBD are unclear, the excessive immune/inflammatory response triggered in the gut wall directly contributes to the epithelial barrier disruption by limiting the reestablishment of intestinal epithelial homeostasis2,3,4. In addition, patients with long-standing colonic inflammation are at high risk of developing colorectal cancer (CRC)5. Other pathologies associated with intestinal epithelial barrier disruption are irritable bowel syndrome, obesity, celiac disease, non-celiac gluten sensitivity, and food allergies6. For these reasons, there is an urgent need for the development of experimental approaches that allow analysis of the integrity of the intestinal epithelial barrier in animal models mimicking the pathogenesis occurring in humans.
Here, we evaluated the gastrointestinal passive paracellular and the transcellular permeability associated to an inflammatory process in the colonic epithelium using a simple technique. To investigate the transmural flow of macromolecules, we measured the passive diffusion of FITC-dextran (4 kDa) and RITC-dextran (10 kDa) in colonic sacs ex vivo. Furthermore, by injecting a fluorescent 10 kDa lysine-fixable dextran into the lumen of the intestine sacs, we specifically identified the areas with high permeability in the inflamed mucosa. The use of apoptosis markers and antibodies against AJ proteins allowed us to demonstrate that high permeability areas in the inflamed mucosa correspond to specific regions where epithelial cells undergo apoptosis and cell-cell junctions are disrupted. This new technique can be used to evaluate the integrity of the epithelium in any model where the intestinal epithelial barrier is compromised.